BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J, Yamasaki S, Takayama T, Makuuchi M. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery. 2005;137:396-402. [PMID: 15800484 DOI: 10.1016/j.surg.2004.10.008] [Cited by in Crossref: 106] [Cited by in F6Publishing: 87] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Kurosaki I, Hatakeyama K, Minagawa M, Sato D. Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor. J Gastrointest Surg. 2008;12:907-918. [PMID: 17968629 DOI: 10.1007/s11605-007-0387-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
2 Boutros C, Somasundar P, Espat NJ. Extrahepatic Cholangiocarcinoma: Current Surgical Strategy. Surgical Oncology Clinics of North America 2009;18:269-88. [DOI: 10.1016/j.soc.2008.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Eitler K, Mathe Z, Papp V, Zalatnai A, Bibok A, Deak PA, Kobori L, Telkes G. Double rarity: malignant masquerade biliary stricture in a situs inversus totalis patient. BMC Surg 2021;21:153. [PMID: 33743673 DOI: 10.1186/s12893-021-01155-w] [Reference Citation Analysis]
4 Nakamoto S, Kumamoto Y, Igarashi K, Fujiyama Y, Nishizawa N, Ei S, Tajima H, Kaizu T, Watanabe M, Yamashita K. Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma. PLoS One 2018;13:e0205864. [PMID: 30325974 DOI: 10.1371/journal.pone.0205864] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
5 Beetz O, Klein M, Schrem H, Gwiasda J, Vondran FWR, Oldhafer F, Cammann S, Klempnauer J, Oldhafer KJ, Kleine M. Relevant prognostic factors influencing outcome of patients after surgical resection of distal cholangiocarcinoma. BMC Surg. 2018;18:56. [PMID: 30103720 DOI: 10.1186/s12893-018-0384-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
6 Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, Sugai T, Wakabayashi G, Ohkohchi N. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007;31:1788-1796. [PMID: 17647056 DOI: 10.1007/s00268-007-9102-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 5.0] [Reference Citation Analysis]
7 van der Gaag NA, Kloek JJ, de Bakker JK, Musters B, Geskus RB, Busch OR, Bosma A, Gouma DJ, van Gulik TM. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Ann Oncol. 2012;23:2642-2649. [PMID: 22532585 DOI: 10.1093/annonc/mds077] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
8 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Ohge H, Sueda T. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011;18:651-8. [PMID: 20945107 DOI: 10.1245/s10434-010-1325-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 128] [Article Influence: 11.9] [Reference Citation Analysis]
9 de Wilde RF, Groot Koerkamp B. Radial margin status should be determined in resected perihilar cholangiocarcinoma. Hepatobiliary Surg Nutr 2019;8:557-9. [PMID: 31673558 DOI: 10.21037/hbsn.2019.07.19] [Reference Citation Analysis]
10 Nishida Y, Sugimoto M, Kojima M, Gotohda N, Konishi M, Takahashi S. Pancreas-preserving resection of lower biliary tract adenocarcinoma: A coring-out technique. Ann Gastroenterol Surg 2017;1:150-5. [PMID: 29863138 DOI: 10.1002/ags3.12021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
11 Han IW, Jang JY, Lee KB, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW. Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. HPB (Oxford) 2014;16:575-81. [PMID: 24308425 DOI: 10.1111/hpb.12193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
12 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
13 Lee KH, Lee KB, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Yi NJ, Lee KW, Suh KS, Jang JJ, Bang YJ. Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma. BMC Cancer 2015;15:721. [PMID: 26475437 DOI: 10.1186/s12885-015-1737-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
14 Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512-522. [PMID: 21808282 DOI: 10.1038/nrgastro.2011.131.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Morofuji N, Ojima H, Onaya H, Okusaka T, Shimada K, Sakamoto Y, Esaki M, Nara S, Kosuge T, Asahina D. Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. J Proteomics. 2012;75:1577-1589. [PMID: 22155129 DOI: 10.1016/j.jprot.2011.11.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
16 Ramacciato G, D'angelo F, Baldini R, Petrucciani N, Antolino L, Aurello P, Nigri G, Bellagamba R, Pezzoli F, Balesh A, Cucchetti A, Cescon M, Gaudio MD, Ravaioli M, Pinna AD. Hepatocellular Carcinomas and Primary Liver Tumors as Predictive Factors for Postoperative Mortality after Liver Resection: A Meta-Analysis of More than 35,000 Hepatic Resections. The American Surgeon 2012;78:456-67. [DOI: 10.1177/000313481207800438] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
17 Shinohara K, Ebata T, Shimoyama Y, Mizuno T, Yokoyama Y, Yamaguchi J, Onoe S, Watanabe N, Nagino M. A Study on Radial Margin Status in Resected Perihilar Cholangiocarcinoma. Annals of Surgery 2021;273:572-8. [DOI: 10.1097/sla.0000000000003305] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
18 Oshiro Y, Sasaki R, Kobayashi A, Murata S, Fukunaga K, Kondo T, Oda T, Ohkohchi N. Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2011;37:60-64. [PMID: 21094016 DOI: 10.1016/j.ejso.2010.10.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
19 Ochiai T, Ikoma H, Inoue K, Komatsu S, Murayama Y, Shiozaki A, Kuriu Y, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Kokuba Y, Sonoyama T, Otsuji E. Long-term survival of a patient with common bile duct cancer after Virchow's node recurrence: Report of a case. Surg Today 2011;41:1432-5. [PMID: 21922372 DOI: 10.1007/s00595-010-4447-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Lee SJ, Hwang S, Ha TY, Kim KH, Ahn CS, Moon DB, Song GW, Jung DH, Park GC, Lee SG. Technical knacks and outcomes of extended extrahepatic bile duct resection in patients with mid bile duct cancer. Korean J Hepatobiliary Pancreat Surg 2013;17:109-12. [PMID: 26155223 DOI: 10.14701/kjhbps.2013.17.3.109] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Blechacz B. Cholangiocarcinoma: Current Knowledge and New Developments. Gut Liver. 2017;11:13-26. [PMID: 27928095 DOI: 10.5009/gnl15568] [Cited by in Crossref: 226] [Cited by in F6Publishing: 198] [Article Influence: 45.2] [Reference Citation Analysis]
22 Ojima H, Kanai Y, Iwasaki M, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Sakamoto M, Hirohashi S. Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma. Cancer Sci 2009;100:62-70. [PMID: 19038006 DOI: 10.1111/j.1349-7006.2008.01009.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
23 Seyama Y, Kokudo N, Makuuchi M. Radical Resection of Biliary Tract Cancers and the Role of Extended Lymphadenectomy. Surgical Oncology Clinics of North America 2009;18:339-59. [DOI: 10.1016/j.soc.2008.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Higuchi R, Ota T, Araida T, Kobayashi M, Furukawa T, Yamamoto M. Prognostic relevance of ductal margins in operative resection of bile duct cancer. Surgery. 2010;148:7-14. [PMID: 20116818 DOI: 10.1016/j.surg.2009.11.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
25 van der Gaag N, Kloek J, de Bakker J, Musters B, Geskus R, Busch O, Bosma A, Gouma D, van Gulik T. Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Annals of Oncology 2012;23:2642-9. [DOI: 10.1093/annonc/mds077] [Reference Citation Analysis]
26 Ojima H, Yoshikawa D, Ino Y, Shimizu H, Miyamoto M, Kokubu A, Hiraoka N, Morofuji N, Kondo T, Onaya H. Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment. Cancer Sci. 2010;101:882-888. [PMID: 20088962 DOI: 10.1111/j.1349-7006.2009.01462.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kim N, Lee H, Min SK, Lee HK. Bile duct segmental resection versus pancreatoduodenectomy for middle and distal common bile duct cancer. Ann Surg Treat Res 2018;94:240-6. [PMID: 29732355 DOI: 10.4174/astr.2018.94.5.240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Yohanathan L, Croome KP, Traynor M, Puig CA, Mara KC, Cleary SP, Nagorney DM. Significance of proximal ductal margin status after resection of hilar cholangiocarcinoma. HPB (Oxford) 2021;23:109-17. [PMID: 32593583 DOI: 10.1016/j.hpb.2020.05.002] [Reference Citation Analysis]
29 Choi SB, Park SW, Kim KS, Choi JS, Lee WJ. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol. 2009;99:335-342. [PMID: 19226533 DOI: 10.1002/jso.21238] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
30 Park Y, Hwang DW, Kim JH, Hong SM, Jun SY, Lee JH, Song KB, Jun ES, Kim SC, Park KM. Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection. J Hepatobiliary Pancreat Sci. 2019;26:169-178. [PMID: 30849218 DOI: 10.1002/jhbp.619] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
31 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Hwang S, Jung DH, Ha TY. Retroduodenal resection of the extrahepatic common bile duct with in situ re-implantation of the main pancreatic duct: A report of two cases. Ann Hepatobiliary Pancreat Surg 2020;24:373-80. [PMID: 32843608 DOI: 10.14701/ahbps.2020.24.3.373] [Reference Citation Analysis]
33 Oshiro Y, Sasaki R, Fukunaga K, Kondo T, Oda T, Takahashi H, Ohkohchi N. Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2013;20:389-95. [PMID: 23138964 DOI: 10.1007/s00534-012-0550-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
34 Kim YJ, Kim K, Min SK, Nam EM. Role of adjuvant radiotherapy for localized extrahepatic bile duct cancer. Br J Radiol. 2017;90:20160807. [PMID: 28118028 DOI: 10.1259/bjr.20160807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
35 Shiraki T, Kuroda H, Takada A, Nakazato Y, Kubota K, Imai Y. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma. World J Gastroenterol 2018; 24(12): 1332-1342 [PMID: 29599608 DOI: 10.3748/wjg.v24.i12.1332] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
36 Akamatsu N, Sugawara Y, Osada H, Okada T, Itoyama S, Komagome M, Shin N, Ishida T, Ozawa F, Hashimoto D. Preoperative evaluation of the longitudinal spread of extrahepatic bile duct cancer using multidetector computed tomography. J Hepatobiliary Pancreat Surg 2009;16:216-22. [PMID: 19214370 DOI: 10.1007/s00534-009-0045-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
37 Kim JE, Lee JM, Kim SH, Baek JH, Moon SK, Yu IS, Lee JY, Han JK, Choi BI. Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography. Radiology. 2010;257:364-372. [PMID: 20829532 DOI: 10.1148/radiol.10092105] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
38 D’amico FE, Mescoli C, Caregari S, Pasquale A, Billato I, Alessandris R, Lanari J, Bassi D, Boetto R, D’amico F, Vitale A, Lonardi S, Gringeri E, Cillo U. Impact of Positive Radial Margin on Recurrence and Survival in Perihilar Cholangiocarcinoma. Cancers 2022;14:1680. [DOI: 10.3390/cancers14071680] [Reference Citation Analysis]
39 Kawai M, Tani M, Kobayashi Y, Tsuji T, Tabuse K, Horiuchi T, Oka M, Yamaguchi K, Sakata Y, Shimomura T. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. Am J Surg. 2010;199:447-452. [PMID: 19596119 DOI: 10.1016/j.amjsurg.2009.01.019] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
40 Ojima H. Clinicopathological significance of growth factors and their receptors as potential therapeutic targets for biliary tract carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2012;19:319-25. [DOI: 10.1007/s00534-011-0497-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Petrelli F, Ghidini M, Ghidini A, Sgroi G, Vavassori I, Petrò D, Cabiddu M, Aiolfi A, Bonitta G, Zaniboni A, Rausa E. Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis. Surg Today 2021. [PMID: 33389174 DOI: 10.1007/s00595-020-02192-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13(10): 1505-1515 [PMID: 17461441 DOI: 10.3748/wjg.v13.i10.1505] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
43 Kobayashi H, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Sueda T. Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection. Ann Surg 2012;256:288-96. [PMID: 22580938 DOI: 10.1097/SLA.0b013e3182536a42] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
44 Bahra M. [Surgical treatment of distal cholangiocarcinoma]. Chirurg 2021;92:788-95. [PMID: 34232340 DOI: 10.1007/s00104-021-01453-2] [Reference Citation Analysis]
45 Esposito I, Schirmacher P. Pathological aspects of cholangiocarcinoma. HPB (Oxford). 2008;10:83-86. [PMID: 18773061 DOI: 10.1080/13651820801992609] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
46 Cho A, Yamamoto H, Kainuma O, Muto Y, Yanagibashi H, Tonooka T, Masuda T. Laparoscopy in the management of hilar cholangiocarcinoma. World J Gastroenterol 2014; 20(41): 15153-15157 [PMID: 25386064 DOI: 10.3748/wjg.v20.i41.15153] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
47 Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512-522. [PMID: 21808282 DOI: 10.1038/nrgastro.2011.131] [Cited by in Crossref: 404] [Cited by in F6Publishing: 399] [Article Influence: 36.7] [Reference Citation Analysis]
48 Miura F, Sano K, Amano H, Toyota N, Wada K, Yoshida M, Hayano K, Matsubara H, Takada T. Evaluation of portal vein invasion of distal cholangiocarcinoma as borderline resectability. J Hepatobiliary Pancreat Sci 2015;22:294-300. [DOI: 10.1002/jhbp.198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
49 Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ. Prognostic factors in patients with middle and distal bile duct cancers. World J Gastroenterol 2014; 20(21): 6658-6665 [PMID: 24914391 DOI: 10.3748/wjg.v20.i21.6658] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
50 Sakamoto Y, Nara S, Kishi Y, Esaki M, Shimada K, Kokudo N, Kosuge T. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery. 2013;153:794-800. [PMID: 23415082 DOI: 10.1016/j.surg.2012.11.024] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
51 Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
52 Sakamoto Y, Shimada K, Nara S, Esaki M, Ojima H, Sano T, Yamamoto J, Kosuge T. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg. 2010;14:335-343. [PMID: 19902311 DOI: 10.1007/s11605-009-1072-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
53 Park MS, Lee DK, Kim MJ, Lee WJ, Yoon DS, Lee SJ, Lim JS, Yu JS, Cho JY, Kim KW. Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma. J Comput Assist Tomogr 2006;30:362-7. [PMID: 16778607 DOI: 10.1097/00004728-200605000-00003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
54 Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T. Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg 2007;31:337-42; discussion 343-4. [PMID: 17006609 DOI: 10.1007/s00268-006-0224-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
55 Capobianco I, Rolinger J, Nadalin S. Resection for Klatskin tumors: technical complexities and results. Transl Gastroenterol Hepatol. 2018;3:69. [PMID: 30363698 DOI: 10.21037/tgh.2018.09.01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
56 Hibi T, Sakamoto Y, Tochigi N, Ojima H, Shimada K, Sano T, Kosuge T. Extended right hemihepatectomy as a salvage operation for recurrent bile duct cancer 3 years after pancreatoduodenectomy. Jpn J Clin Oncol. 2006;36:176-179. [PMID: 16478793 DOI: 10.1093/jjco/hyi232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
57 Hwang S, Lee SG, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH. Extended extrahepatic bile duct resection to avoid performing pancreatoduodenectomy in patients with mid bile duct cancer. Dig Surg. 2008;25:74-79. [PMID: 18292664 DOI: 10.1159/000118025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
58 McNally ME, Collins A, Wojcik SE, Liu J, Henry JC, Jiang J, Schmittgen T, Bloomston M. Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB (Oxford). 2013;15:260-264. [PMID: 23458262 DOI: 10.1111/j.1477-2574.2012.00523.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
59 Sugita S, Sasaki A, Iwaki K, Uchida H, Kai S, Shibata K, Ohta M, Kitano S. Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. Eur J Surg Oncol. 2008;34:339-345. [PMID: 17400417 DOI: 10.1016/j.ejso.2007.02.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
60 Ishihara S, Miyakawa S, Takada T, Takasaki K, Nimura Y, Tanaka M, Miyazaki M, Nagakawa T, Kayahara M, Horiguchi A. Status of surgical treatment of biliary tract cancer. Dig Surg. 2007;24:131-136. [PMID: 17446708 DOI: 10.1159/000101901] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
61 Verbeke CS, Gladhaug IP. Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg. 2012;99:1036-1049. [PMID: 22517199 DOI: 10.1002/bjs.8734] [Cited by in Crossref: 109] [Cited by in F6Publishing: 91] [Article Influence: 10.9] [Reference Citation Analysis]
62 Furuse J. Postoperative adjuvant treatments for biliary tract cancer. J Hepatobiliary Pancreat Surg 2008;15:463-7. [DOI: 10.1007/s00534-008-1358-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
63 Murakami Y, Uemura K, Hayasidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection. Dig Dis Sci. 2009;54:1360-1364. [PMID: 18975086 DOI: 10.1007/s10620-008-0492-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
64 Miura F, Sano K, Amano H, Toyota N, Wada K, Tokairin T, Kondo F, Hayano K, Matsubara H, Takada T. Is it possible to define early distal cholangiocarcinoma? Langenbecks Arch Surg 2016;401:25-32. [DOI: 10.1007/s00423-015-1351-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Mavros MN, Xu L, Maqsood H, Gani F, Ejaz A, Spolverato G, Al-Refaie WB, Frank SM, Pawlik TM. Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis. Ann Surg Oncol. 2015;22:4382-4391. [PMID: 26293837 DOI: 10.1245/s10434-015-4823-6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 9.6] [Reference Citation Analysis]
66 Kaira K, Sunose Y, Ohshima Y, Ishioka NS, Arakawa K, Ogawa T, Sunaga N, Shimizu K, Tominaga H, Oriuchi N. Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer. 2013;13:482. [PMID: 24131658 DOI: 10.1186/1471-2407-13-482] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
67 Stremitzer S, Stift J, Laengle J, Schwarz C, Kaczirek K, Jones RP, Quinn LM, Fenwick SW, Diaz-Nieto R, Poston GJ, Malik HZ. Prognosis and Circumferential Margin in Patients with Resected Hilar Cholangiocarcinoma. Ann Surg Oncol 2021;28:1493-8. [PMID: 32914390 DOI: 10.1245/s10434-020-09105-1] [Reference Citation Analysis]
68 Koo T, Park HJ, Kim K. Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives. World J Clin Cases 2019; 7(11): 1242-1252 [PMID: 31236388 DOI: 10.12998/wjcc.v7.i11.1242] [Reference Citation Analysis]
69 Kamposioras K, Anthoney A, Fernández Moro C, Cairns A, Smith AM, Liaskos C, Verbeke CS. Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer. Br J Surg 2014;101:89-99. [PMID: 24375301 DOI: 10.1002/bjs.9367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
70 Ahn KS, Kang KJ, Kang YN, Kim YH, Kim TS. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma. BMC Gastroenterol 2016;16:21. [PMID: 26911927 DOI: 10.1186/s12876-016-0444-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
71 Zhou Y, Liu S, Wu L, Wan T. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian J Surg. 2017;40:129-138. [PMID: 26337377 DOI: 10.1016/j.asjsur.2015.07.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
72 Khalifa MA, Maksymov V, Rowsell CH, Hanna S. A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen. HPB (Oxford) 2007;9:146-9. [PMID: 18333131 DOI: 10.1080/13651820701278273] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
73 Courtin-tanguy L, Turrini O, Bergeat D, Truant S, Darnis B, Delpero JR, Mabrut JY, Regenet N, Sulpice L. Multicentre study of the impact of factors that may affect long-term survival following pancreaticoduodenectomy for distal cholangiocarcinoma. HPB 2018;20:405-10. [DOI: 10.1016/j.hpb.2017.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
74 Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Ann Surg Oncol 2008;15:590-9. [PMID: 18057991 DOI: 10.1245/s10434-007-9687-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
75 Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma. J Surg Oncol. 2007;95:207-212. [PMID: 17278119 DOI: 10.1002/jso.20668] [Cited by in Crossref: 86] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
76 Moazzami B, Majidzadeh-A K, Dooghaie-Moghadam A, Eslami P, Razavi-Khorasani N, Iravani S, Khoshdel A, Shahi F, Dashti H, Mehrvar A, Nassiri Toosi M. Cholangiocarcinoma: State of the Art. J Gastrointest Cancer 2020;51:774-81. [PMID: 32157571 DOI: 10.1007/s12029-020-00390-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
77 Kim EJ, Chung DH, Kim YJ, Kim YS, Park YH, Kim KK, Cho JH. Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.PLoS One. 2018;13:e0206694. [PMID: 30439965 DOI: 10.1371/journal.pone.0206694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
78 Chin KM, Di Martino M, Syn N, Ielpo B, Hilal MA, Goh BKP, Koh YX, Prieto M. Re-appraising the role of lymph node status in predicting survival in resected distal cholangiocarcinoma - A meta-analysis and systematic review. Eur J Surg Oncol 2021;47:1267-77. [PMID: 33549378 DOI: 10.1016/j.ejso.2021.01.004] [Reference Citation Analysis]
79 Wellner UF, Shen Y, Keck T, Jin W, Xu Z. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival. Surg Today 2017;47:271-9. [DOI: 10.1007/s00595-016-1362-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
80 Matthaei H, Lingohr P, Strässer A, Dietrich D, Rostamzadeh B, Glees S, Roering M, Möhring P, Scheerbaum M, Stoffels B. Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications. Virchows Arch. 2015;466:133-141. [PMID: 25425476 DOI: 10.1007/s00428-014-1689-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
81 Bonet Beltrán M, Allal AS, Gich I, Solé JM, Carrió I. Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies. Cancer Treat Rev. 2012;38:111-119. [PMID: 21652148 DOI: 10.1016/j.ctrv.2011.05.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
82 Lee HG, Lee SH, Yoo DD, Paik KY, Heo JS, Choi SH, Choi DW. Carcinoma of the middle bile duct: Is bile duct segmental resection appropriate? World J Gastroenterol 2009; 15(47): 5966-5971 [PMID: 20014461 DOI: 10.3748/wjg.15.5966] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
83 Iso Y, Kita J, Kato M, Shimoda M, Kubota K. When hepatic-side ductal margin is positive in N+ cases, additional resection of the bile duct is not necessary to render the negative hepatic-side ductal margin during surgery for extrahepatic distal bile duct carcinoma. Med Sci Monit 2014;20:471-5. [PMID: 24657986 DOI: 10.12659/MSM.889714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
84 Uccella S, Ghezzi F, Cromi A, Bogani G, Formenti G, Donadello N, Serati M, Bolis P. Perioperative allogenic blood transfusions and the risk of endometrial cancer recurrence. Arch Gynecol Obstet 2013;287:1009-16. [PMID: 23229580 DOI: 10.1007/s00404-012-2668-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
85 Liu K. Distal cholangiocarcinoma. J Surg Oncol 2007;95:192-3. [PMID: 17323332 DOI: 10.1002/jso.20666] [Reference Citation Analysis]
86 Kaneoka Y, Yamaguchi A, Isogai M, Kumada T. Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg. 2010;34:2662-2670. [PMID: 20607255 DOI: 10.1007/s00268-010-0702-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
87 Konishi M, Iwasaki M, Ochiai A, Hasebe T, Ojima H, Yanagisawa A. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. British Journal of Surgery 2010;97:1363-8. [DOI: 10.1002/bjs.7122] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
88 Shimura T, Kofunato Y, Okada R, Yashima R, Koyama Y, Araki K, Kuwano H, Takenoshita S. Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma. Oncol Lett 2017;14:819-29. [PMID: 28693238 DOI: 10.3892/ol.2017.6252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
89 Chung MJ, Lee KJ, Bang S, Park SW, Kim KS, Lee WJ, Song SY, Chung JB, Park JY. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. Ann Surg Oncol. 2011;18:1651-1656. [PMID: 21210227 DOI: 10.1245/s10434-010-1529-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
90 Kwon HJ, Kim SG, Chun JM, Hwang YJ. Classifying extrahepatic bile duct metachronous carcinoma by de novo neoplasia site. World J Gastroenterol 2014; 20(11): 3050-3055 [PMID: 24659897 DOI: 10.3748/wjg.v20.i11.3050] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
91 Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T. Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 2009;250:950-6. [PMID: 19953713 DOI: 10.1097/sla.0b013e3181b0fc8b] [Cited by in Crossref: 82] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
92 Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008;15:41-54. [PMID: 18274843 DOI: 10.1007/s00534-007-1279-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 9.8] [Reference Citation Analysis]
93 Hamura R, Haruki K, Taniai T, Yanagaki M, Shirai Y, Furukawa K, Usuba T, Fujioka S, Okamoto T, Nakabayashi Y, Uwagawa T, Ikegami T. The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis. Int J Clin Oncol. [DOI: 10.1007/s10147-022-02165-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Chen Z, Yu B, Bai J, Li Q, Xu B, Dong Z, Zhi X, Li T. The Impact of Intraoperative Frozen Section on Resection Margin Status and Survival of Patients Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma. Front Oncol 2021;11:650585. [PMID: 34012916 DOI: 10.3389/fonc.2021.650585] [Reference Citation Analysis]